GPR35 and metabolic dysfunction-associated steatotic liver disease: These discoveries offer valuable insights into the gene expression alterations linked to the presence or absence of GPR35 and different dietary conditions, providing a clearer understanding of the potential role of GPR35 in the progression of MASLD and MASH.